EU releases 144 mn euro for new rare disease research

The European Union on Thursday pledged 144 million euros of fresh funding for research on rare diseases that currently affect some 30 million Europeans, the majority of them children.

The funding will go to 26 research projects in 29 countries "in Europe and beyond" to better diagnose and treat cardiovascular, metabolic and immunological disorders, the European Commission said.

"Most affect children and most of them are devastating genetic disorders resulting in greatly reduced quality of life and premature death," said the EU commissioner for research and innovation Maire Geoghegan-Quinn.

"We hope that these new research projects will bring patients, their families and health professionals closer to a cure and support them in their daily battle with disease."

Among the different projects are a new "bioartificial" liver support system to treat , powerful data processing to develop novel diagnostic tools, biomarkers and screening strategies for therapeutic agents against rare kidney diseases, and the clinical development of a drug to treat alkaptonuria, a genetic disorder which leads to a severe and early-onset form of arthritis, heart disease and disability for which there is currently no effective treatment.

Many of the new projects will contribute to the International Rare Diseases (IRDiRC), the biggest collective rare diseases research effort world-wide.

A disease is defined as rare in Europe when it affects not more than 1 in every 2,000 people.

But because there are between 6,000 to 8,000 rare diseases, together they affect a significant share of the population.

Most rare diseases have whilst others are the result of infections, allergies and environmental causes. They are usually chronically debilitating or even life-threatening.

add to favorites email to friend print save as pdf

Related Stories

What is the cost of rare diseases such as Friedreich's Ataxia?

Feb 27, 2013

What is the cost of rare diseases such as Friedreich's Ataxia? By analyzing direct and indirect costs of care research in BioMed Central's open access journal Orphanet Journal of Rare Diseases calculated that conservatively this r ...

Recommended for you

New research software automates DNA analysis

Oct 20, 2014

At the core of medical research is problem-solving, which is exactly what two PhD scientists did when they set out to eliminate a common, time-consuming task performed in research laboratories around the world.

User comments